Stem Cell Therapy for Early Alzheimer's Disease (NCT06775964)
Mesenchymal Stem Cell Therapy for Early Alzheimer's Disease
🩺 Plain-English Summary (8th-Grade Level)
The goal of this clinical trial is to learn if stem cell therapy works to treat brain inflammation in adults. Inflammation in the brain may be involved in adults who have memory or thinking problems. The stem cells will be taken from participant's fat samples, processed and given back to participants, so they are their own donor. The main questions this trial aims to answer are: * Does stem cell therapy reduce inflammation in the brain? * Does stem cell therapy improve brain activity? * Does stem cell therapy slow down progression to Alzheimer's disease? Participants will: * Have a small fat biopsy taken at a doctor's office to process stem cells * Receive 4 infusions of stem cells, through a vein in the arm over 12 weeks * Visit the clinic every 2-4 weeks for the first 4 months and then every 1-2 months for 8 months for checkups and tests
Who can join: Review the eligibility criteria below.
Location: The University of Texas Health Science Center at Houston (UTHealth) — Houston, Texas
Age range: 60 Years to 80 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- The University of Texas Health Science Center at Houston (UTHealth) — Houston, Texas
📞 Contact the Study Coordinator
Phone: (713) 486-0531
Email: Harshali.Patel@uth.tmc.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Cognitive Dysfunction
- PREsurgical Cognitive Evaluation Via Digital clockfacEdrawing — Gainesville, Florida
- Network-targeted Theta-burst Stimulation for Episodic Memory Improvement in Mild Cognitive Impairment — Los Angeles, California
- Fareon Open Label Device Clinical Trial — New York, New York
- A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7) — Chandler, Arizona
- ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults — New Brunswick, New Jersey
Explore by condition: All Cognitive Dysfunction clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.